Madison, WI, United States of America

Cheyann Wetteland

This inventor holds 1 USPTO granted patent. Top assignee: Innosense LLC. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheyann Wetteland. Retrieved from https://idiyas.com/inventor/cheyann-wetteland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cheyann Wetteland: Innovator in Drug Delivery Systems

Introduction

Cheyann Wetteland is an accomplished inventor based in Madison, WI (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative use of nanocellulose.

Latest Patents

Wetteland holds a patent for "Nanocellulose as an embedding matrix and applications thereof." This versatile drug delivery system utilizes plant-based nanocellulose to provide high loading and extended release for virtually any drug. The system is composed of nanocrystalline cellulose that is chemically cross-linked to form a hydrogel. This hydrogel-based drug delivery system can be functionalized to support extended release of oral dosing, which helps relieve patient burden and enhances quality of life.

Career Highlights

Cheyann Wetteland is currently associated with Innosense LLC, where he continues to develop innovative solutions in the field of drug delivery. His work has garnered attention for its potential to improve patient outcomes through advanced technology.

Collaborations

Wetteland collaborates with talented individuals such as Anamika Ray and Harini Madakashira, who contribute to the innovative environment at Innosense LLC.

Conclusion

Cheyann Wetteland's work in nanocellulose-based drug delivery systems exemplifies the intersection of innovation and healthcare. His contributions are paving the way for improved patient care and enhanced therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…